TerrAscend Corp. (TSND)

Investors Overview

Latest News

October 1, 2024 • 8:30 am EDT

TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing

Read Press Release View All News

September 5, 2024 • 8:30 am EDT

TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC

August 20, 2024 • 8:30 am EDT

TerrAscend Announces $10 Million Share Repurchase Program

August 8, 2024 • 4:10 pm EDT

TerrAscend Reports Second Quarter 2024 Financial Results

Latest Presentation

August 13, 2024

August 2024 Investor Presentation

View Presentation View All Presentations

Latest Event

September 18, 2024 • 8:00 am EDT

ATB Capital Markets 2024 Life Sciences Institutional Investor Conference

View All Events

Latest Financial Results

Q2 2024

Quarter Ended Jun 30, 2024

Earnings Release PDF

Earnings Webcast

Presentation

10-Q PDF

XBRL

Board of Directors

The TerrAscend Board of Directors is made up of five members collectively bringing a wealth of knowledge and experience to guide strategic decision-making.

Meet the Board

Executive Leadership

The TerrAscend Executive Leadership team is made up of seven team members who drive visionary guidance, innovation, and strategic initiatives.

Meet the Team

Corporate Office

TerrAscend Corp.
357 S. Gulph Rd.
Ste 330
King of Prussia, PA 19406
United States
info@terrascend.com

Investor Relations

ir@terrascend.com

Transfer Agent

Odyssey Trust Company
http://www.odysseycontact.com/

Come Grow with Us

Learn more about career opportunities or become an Investor.

Career Opportunities Investor Relations

Experience Our Products

Learn more about our brands and award-winning dispensaries.

Our Brands Our Stores